Lab-based “gut” model to help study of health-promoting bacteria being developed by NCIMB and The Rowett Institute in new KTP project

Aberdeen-based biotechnology company NCIMB is collaborating with the pioneering Rowett Institute to develop a tool that will improve understanding of microbes that have important roles in human health and disease, and support development of new treatments for inflammatory bowel disease, liver disease and cancer. The work has received funding from Innovate UK.

Read More
Member NewsValerie Evans